Advertisement

The Clinical Management of Penile Cancer

  • Rajiv Sarin
  • Hemant B. Tongaonkar
  • Reena Engineer

Abstract

Penile malignancies are uncommon in most parts of the world, but there is a striking geographical variation around the world. While the age-adjusted incidence rate is less than 1 per 100,000 in Europe and North America, in parts of South America, Africa, and India, the incidence is as high as 12 per 100,000 men [1]. Even within a country, there are marked regional variations. In Brazil the incidence of penile cancer is as high as 28 and 50 per 100,000 men in the cities of Sao Paulo and Recife, respectively [2]. Within Africa, the highest incidence has been reported from Uganda, where it is the most common cancer in males [3]. In India the disease is more common in the rural population with an incidence of 3 per 100,000 people accounting for more than 6% of all cancers in rural men [4].

Keywords

Penile Cancer Urologic Cancer Penile Carcinoma Groin Dissection Inguinal Lymphadenectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tomatis L, Aitio A, Day NE, et al (Eds). Cancer: Causes, Occurrence and Control. Lyon: IARC Scientific Publications No. 100, 1990.Google Scholar
  2. 2.
    D’Ancona CAL, Botega NJ, Moraes CD, et al. Quality of life after partial penectomy for penile carcinoma. Adult Urol 1997;50:593–596.Google Scholar
  3. 3.
    Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004;5:240–247.PubMedCrossRefGoogle Scholar
  4. 4.
    Indian Council of Medical Research (ICMR), National Cancer Registry Programme. Consolidated Report of the Population Based Cancer Registries 1990–1996. New Delhi: ICMR, 2001.Google Scholar
  5. 5.
    Dillner J, von Krogh G, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000;205:189–193.PubMedCrossRefGoogle Scholar
  6. 6.
    Kamat MR, Kulkarni JN, Tongaonkar HB. Carcinoma of the penis: the Indian experience. J Surg Oncol 1993;52:50–55.PubMedCrossRefGoogle Scholar
  7. 7.
    Magoha GA, Ngumi ZW. Cancer of the penis at Kenyatta National Hospital. East Afr Med J 2000;77:526–530.PubMedGoogle Scholar
  8. 8.
    Sandeman TF. Carcinoma penis. Australas Radiol 1990;34:12–16.PubMedGoogle Scholar
  9. 9.
    Soria JC, Fizazi K, Piron D, et al. Squamous cell carcinoma of the penis:multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 1997;8:1089–1098.PubMedCrossRefGoogle Scholar
  10. 10.
    Cubilla AL, Meijer CJ, Young RH. Morphological features of epithelial abnormalities and precancerous lesions of the penis. Scand J Urol Nephrol Suppl 2000;205:215–219.PubMedCrossRefGoogle Scholar
  11. 11.
    Cubilla AL, Barreto J, Caballero C, Ayala G, Riveros G. Pathological features of epidermoid carcinoma of the penis. Am J Surg Pathol 1993;17:753–763.PubMedCrossRefGoogle Scholar
  12. 12.
    Ayappan K, Ananthakrishnan N, Sankaran V. Can regional lymph node involvement be predicted in patients with carcinoma of the penis? Br J Urol 1994;73:549–553.Google Scholar
  13. 13.
    Solsona E, Iborra I, Ricos JV, et al. Corpus cavernosum invasion and tumour grade in the prediction of lymph node condition of penile carcinoma. Eur Urol 1992;22:115–118.PubMedGoogle Scholar
  14. 14.
    Villavicencio H, Rubio-Briones J, Regalado R, Chechile G, Algaba F, Palou J. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997;32:442–447.PubMedGoogle Scholar
  15. 15.
    Pizzocaro G, Piva L, Nicolai N. Treatment of lymphatic metastasis of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan. Arch Ital Urol Androl 1996;68:169–172.PubMedGoogle Scholar
  16. 16.
    Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 1989;142:1478–1482.PubMedGoogle Scholar
  17. 17.
    Theodorescu D, Russo P, Zhang ZF, Morash C, Fair WR. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol 1996;155:1626–1631.PubMedCrossRefGoogle Scholar
  18. 18.
    Heyns CF, van Vollenhoven P, Steenkamp JW, Allen FJ, van Velden DJ. Carcinoma of the penis—appraisal of a modified tumour-staging system. Br J Urol 1997;80:307–312.PubMedGoogle Scholar
  19. 19.
    Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996;156:1637–1642.PubMedCrossRefGoogle Scholar
  20. 20.
    Horenblas S, Van Tinteren H, Delemarre JFM, Moonen LMF, Lustig V, Kroger R. Squamous cell carcinoma of the penis: accuracy of tumour, node and metastases classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 1991;146:1279–1283.PubMedGoogle Scholar
  21. 21.
    Horenblas S, Kroger R, Gallee MPW, Newling DWW, Van Tinteren H. Ultrasound in squamous cell carcinoma of the penis: a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology 1994;43:702–707.PubMedCrossRefGoogle Scholar
  22. 22.
    Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C. Clinical and sonographic findings in carcinoma of the penis. J Clin Ultrasound 2000;28:399–406.PubMedCrossRefGoogle Scholar
  23. 23.
    Vapnek JM, Hricak H, Carroll PR. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am 1992;19:257–266.PubMedGoogle Scholar
  24. 24.
    Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993;72:817–819.PubMedGoogle Scholar
  25. 25.
    Jackson SM. The treatment of carcinoma of the penis. Br J Surg 1966;53:33–35.PubMedCrossRefGoogle Scholar
  26. 26.
    Horenblas S, Van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 1994;151:1239–1243.PubMedGoogle Scholar
  27. 27.
    Harden SV, Tan LT. Treatment of localized carcinoma of the penis: a survey of current practice in the UK. Clin Oncol (R Coll Radiol) 2001;13:284–287.Google Scholar
  28. 28.
    Rozan R, Albuisson E, Giraud B, et al. Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol 1995;36:83–93.PubMedCrossRefGoogle Scholar
  29. 29.
    Delannes M, Malavaud B, Douchez J, Bonnet J, Daly NJ. Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 1992;24:479–483.PubMedGoogle Scholar
  30. 30.
    Ravi R, Chaturvedi HK, Sastry DVLN. Role of radiation therapy in the treatment of carcinoma of the penis. Br J Urol 1994;74:646–651.PubMedGoogle Scholar
  31. 31.
    Sarin R, Norman AR, Steel GG, Horwich A. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 1997;38:713–722.PubMedCrossRefGoogle Scholar
  32. 32.
    Chaudhary AJ, Ghosh S, Bhalavat RL, Kulkarni JN, Sequeira BV. Interstitial brachytherapy in carcinoma of the penis. Strahlenther Onkol 1999;175:17–20.PubMedGoogle Scholar
  33. 33.
    Narayana AS, Olney LE, Loening SA, Weimar G, Culp DA. Carcinoma of the penis: analysis of 219 cases. Cancer 1982;49:2185–2191.PubMedCrossRefGoogle Scholar
  34. 34.
    Hardner GJ, Bhanalaph T, Murphy GP, Albert DJ, Moore RH. Carcinoma of the penis: analysis of therapy in 100 consecutive cases. J Urol 1972;108:428–430.PubMedGoogle Scholar
  35. 35.
    McDougal WS, Kirchner FK Jr, Edwards RH, Killon LT. Treatment of carcinoma of the penis: the case of primary lymphadenectomy. J Urol 1986;136:38–41.PubMedGoogle Scholar
  36. 36.
    Jensen MS. Cancer of the penis in Denmark 1942 to 1962 (511 cases). Dan Med Bull 1977;24:66–72.PubMedGoogle Scholar
  37. 37.
    Horenblas S, Van Tinteren H, Delemare JFM. Squamous cell carcinoma of the penis: treatment of the primary tumour. J Urol 1992;147:1533–1538.PubMedGoogle Scholar
  38. 38.
    Mohs FE, Snow SN, Messing EM, Kuglitsch ME. Microscopically controlled surgery in the treatment of carcinoma of the penis. J Urol 1985;133:961–966.PubMedGoogle Scholar
  39. 39.
    Brown MD, Zachary CB, Grekin RC, Swanson NA. Penile tumors: their management by Mohs micrographic surgery. J Dermatol Surg Oncol 1987;13:1163–1167.PubMedGoogle Scholar
  40. 40.
    Bandiermonte, Santoro O, Boracchi P, Piva L, Pizzocaro G, DePalo G. Total resection of glans penis surface by CO2 laser microsurgery. Acta Oncol 1988;27:575–578.Google Scholar
  41. 41.
    Rothenberger KH. Value of the neodymium YAG laser in the therapy of penile carcinoma. Eur Urol 1986;12(suppl 1):34–36.PubMedGoogle Scholar
  42. 42.
    Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 2003;169:2118–2121.PubMedCrossRefGoogle Scholar
  43. 43.
    Frimberger D, Hungerhuber E, Zaak D, Waidelich R, Hofstetter A, Schneede P. Penile carcinoma. Is Nd:YAG laser therapy radical enough? J Urol 2002;168:2418–2421.PubMedCrossRefGoogle Scholar
  44. 44.
    Van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol 2001;166:670–671.Google Scholar
  45. 45.
    Neave F, Neal AJ, Hoskin PJ, Hope-Stone HF. Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin Oncol 1993;5:207–210.CrossRefGoogle Scholar
  46. 46.
    Duncan W, Jackson SM. Treatment of early cancer of penis with megavoltage x-rays. Clin Radiol 1972;23:246–248.PubMedCrossRefGoogle Scholar
  47. 47.
    Modig H, Duchek M, Sjodin JG. Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol 1993;32:653–655.PubMedGoogle Scholar
  48. 48.
    Lindegaard JC, Nielsen OS, Lundbeck FA, Mamsen A, Studstrup HN, von der Maase H. A retrospective analysis of 82 cases of cancer of the penis. Br J Urol 1996;77:883–890.PubMedGoogle Scholar
  49. 49.
    Hoffman MA, Renshaw AA, Loughlin KR. Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer. 1999;85:1565–1568.PubMedCrossRefGoogle Scholar
  50. 50.
    Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int 2000;85:299–301.PubMedCrossRefGoogle Scholar
  51. 51.
    Bissada NK, Morcos RR, El-Senoussi M. Post-circumcision carcinoma of the penis. I. Clinical aspects. J Urol 1986;135:283–285.PubMedGoogle Scholar
  52. 52.
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466.PubMedCrossRefGoogle Scholar
  53. 53.
    Scappini P, Piscioli F, Pusiol T, Hofstetter A, Rothenberger KH, Luciani L. Penile cancer: aspiration biopsy cytology for staging. Cancer 1986;58:1526–1533.PubMedCrossRefGoogle Scholar
  54. 54.
    Perinetti EP, Crane DC, Catalona WJ. Unreliability of sentinel node biopsy for staging penile carcinoma. J Urol 1980;124:734–735.PubMedGoogle Scholar
  55. 55.
    Pettaway CA, Pisters LL, Dinney CP, et al. Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. J Urol 1995;154:1999–2003.PubMedCrossRefGoogle Scholar
  56. 56.
    Valdes Olmos RA, Tanis PJ, Hoefnagel CA, et al. Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med 2001;28:581–585.PubMedCrossRefGoogle Scholar
  57. 57.
    Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, de Jong D, Nieweg OE. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000;163:100–104.PubMedCrossRefGoogle Scholar
  58. 58.
    Han KR, Brogle BN, Goydos J, Perrotti M, Cummings KB, Weiss RE. Lymphatic mapping and intraoperative lymphoscintigraphy for identifying the sentinel node in penile tumors. Urology 2000;55:582–585.PubMedCrossRefGoogle Scholar
  59. 59.
    Tanis PJ, Lont AP, Meinhardt W, Olmos RA, Nieweg OE, Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 2002;168:76–80.PubMedCrossRefGoogle Scholar
  60. 60.
    Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170:783–786.PubMedCrossRefGoogle Scholar
  61. 61.
    Senthil Kumar MP, Ananthakrishnan N, Prema V. Predicting regional lymph node metastasis in carcinoma of penis: a comparison between fine needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 1998;81:453–457.PubMedGoogle Scholar
  62. 62.
    Sanchez-Oritz RF, Pettaway CA. Natural history, management, and surveillance of recurrent squamous cell penile carcinoma: a risk based approach. Urol Clin North Am 2003;30:853–867.CrossRefGoogle Scholar
  63. 63.
    Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr. Penile cancer: relation of extent of nodal metastasis to survival. J Urol 1987;137:880–882.PubMedGoogle Scholar
  64. 64.
    Fossa SD, Hall KS, Johannessen NB, Urnes T, Kaalhus O. Cancer of the penis. Experience at the Norwegian Radium Hospital 1974–1985. Eur Urol 1987;13:372–377.PubMedGoogle Scholar
  65. 65.
    Ornellas AA, Seixas LC, Marota A. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 1994;151:1244–1249.PubMedGoogle Scholar
  66. 66.
    Johnson DE, Lo RK. Management of regional lymph nodes in penile carcinoma: five year results following therapeutic groin dissections. Urology 1984;24:308–311.PubMedCrossRefGoogle Scholar
  67. 67.
    Beggs JH, Spratt JS. Epidermoid carcinoma of the penis. J Urol 1961;91:166–172.Google Scholar
  68. 68.
    Frew ID, Jefferies JD, Swinney J. Carcinoma of penis. Br J Urol 1967;39:398–404.PubMedGoogle Scholar
  69. 69.
    Baker BH, Spratt JS, Perez-Mesa C. Carcinoma of the penis. J Urol 1976;116:458–461.PubMedGoogle Scholar
  70. 70.
    Tongaonkar HB, Kulkarni JN, Kamat MR. Carcinoma of the penis: relationship of nodal metastases to survival. Indian J Urol 1993;9:54–57.Google Scholar
  71. 71.
    Gursel EO, Georgountzos C, Uson AC, Melicow MM, Veenema RJ. Penile cancer. Urology 1973;1:569–578.PubMedCrossRefGoogle Scholar
  72. 72.
    Assimos DG, Jarow JP. Role of laparoscopic pelvic lymph node dissection in the management of patients with penile cancer and inguinal adenopathy. J Endourol 1994;8:365–369.PubMedGoogle Scholar
  73. 73.
    Fraley EE, Hutchens HC. Radical ilio-inguinal node dissection: the skin bridge technique. A new procedure. J Urol 1972;108:279–281.PubMedGoogle Scholar
  74. 74.
    Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol 1988;140:306–310.PubMedGoogle Scholar
  75. 75.
    Coblentz TR, Theodorescu D. Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis. J Urol 2002;168:1386–1389.PubMedCrossRefGoogle Scholar
  76. 76.
    Jacobellis U. Modified radical inguinal lymphadenectomy for carcinoma of the penis: technique and results. J Urol 2003;169:1349–1352.PubMedCrossRefGoogle Scholar
  77. 77.
    Savant DN, Dalal AV, Patel SG, Bhathena HM, Kavarana NM. Tensor fasciae lata myocutaneous flap reconstruction following ilioinguinal node dissection. Eur J Plast Surg 1996;19:174–177.CrossRefGoogle Scholar
  78. 78.
    Goette DK, Carson TE. Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. Cancer 1976;38:1498–1502.PubMedCrossRefGoogle Scholar
  79. 79.
    Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002;46:545–548.PubMedCrossRefGoogle Scholar
  80. 80.
    Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003;170:359–365.PubMedCrossRefGoogle Scholar
  81. 81.
    Hussein AM, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990;65:433–438.PubMedCrossRefGoogle Scholar
  82. 82.
    Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992;147:630–632.PubMedGoogle Scholar
  83. 83.
    Haas GP, Blumenstein BA, Gagliano RG, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999;161:1823–1825.PubMedCrossRefGoogle Scholar
  84. 84.
    Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol 1997;32:5–15.PubMedGoogle Scholar
  85. 85.
    Kattan J, Culine S, Droz JP, et al. Penile cancer chemotherapy: twelve years’ experience at Institut Gustave-Roussy. Urology 1993;42:559–562.PubMedCrossRefGoogle Scholar
  86. 86.
    Rozan R, Albuisson E, Giraud B, Boiteux JP, Dauplat J. Epithelioma of the penis treated with surgery. Study Group on Urogenital Tumors of the National Federation of the Centers for Cancer Control. Prog Urol 1996;6:926–935.PubMedGoogle Scholar
  87. 87.
    Lindegaard JC, Nielsen OS, Lundbeck FA, Mamsen A, Studstrup HN, von der Maase H. A retrospective analysis of 82 cases of cancer of the penis. Br J Urol 1996;77:883–890.PubMedGoogle Scholar
  88. 88.
    Opjordsmoen S, Waehre H, Aass N, Fossa SD. Sexuality in patients treated for penile cancer: patient’s experience and doctor’s judgement. Br J Urol 1994;73:554–560.PubMedCrossRefGoogle Scholar
  89. 89.
    Ficarra V, Mofferdin A, D’Amico A, et al. Comparison of the quality of life of patients treated by surgery or radiotherapy in epidermoid cancer of the penis. Prog Urol 1999;9:715–720.PubMedGoogle Scholar
  90. 90.
    Munro NP, Thomas PJ, Deutsch GP, Hodson NJ. Penile cancer: a case for guidelines. Ann R Coll Surg Engl 2001;83:180–185.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Rajiv Sarin
    • 1
  • Hemant B. Tongaonkar
    • 2
  • Reena Engineer
    • 3
  1. 1.Advanced Centre for Treatment, Research & Education in Cancer (ACTREC)Tata Memorial CentreMumbaiIndia
  2. 2.Genitourinary and Gynaecological ServicesTata Memorial HospitalMumbaiIndia
  3. 3.Department of Radiation OncologyTata Memorial HospitalMumbaiIndia

Personalised recommendations